DFCO Dalrada Financial Corp.

Dalrada Financial Corporation Enters $104 Billion Carbon Credit Market with Data Mining Innovation

Dalrada Financial Corporation Enters $104 Billion Carbon Credit Market with Data Mining Innovation

Company simplifies the generation, validation, and trading of carbon credits by using energy and climate technology devices, including heat pumps.

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today that it had entered the carbon credit market with a powerful software system and hardware device that manages energy usage while clearing a pathway to a robust revenue stream for the company.

With the global carbon credit market expected to reach $340 billion by 2032, Dalrada’s carbon credit minting solution arrives at an opportune moment. The Company is well positioned to capitalize on the growing potential, and, by capturing just 1% of the expected market, Dalrada and its subsidiaries could anticipate a $3.4 billion market share—in less than 10 years.

“Whether for or commercial use, our system was designed to work in virtually any setting,” said Brian Bonar, Dalrada’s CEO and Founder. “Another huge advantage is that this unique product is essentially plug-and-play and fully integrates with practically any machine that utilizes energy, especially .”

The bullish CEO is all in on the Company’s compatible software and its accompanying hardware device—which is expected to be available in 90 days—noting that the carbon credit minting system is also ideal for a variety of industries, including agriculture, manufacturing, food processing, and more.

The entire system represents a fully-transparent ecosystem and process that analyzes energy use in real-time and historical data from consumers and providers alike. To further ensure legitimacy, the validity and value of each carbon credit is authenticated through robust third-party oversight.

“As climate technology innovators, we’re very excited about our all-in-one solution that will benefit energy users, energy providers, and the environment. I expect revenues to be realized by the end of the 2025 calendar year,” added Bonar.

About Dalrada Corporation

Dalrada Financial Corporation (OTCQB: ) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy and Health Care sectors. Dalrada’s core segments include Dalrada Climate Technology, which offers cutting-edge heat pump technology for industrial and residential applications, and Genefic Specialty Pharmacy, which provides end-to-end prescription services as well as patient advocacy and support.

Dalrada Financial Corporation consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.

For more information, please visit , and follow us on , , , and .

Forward-Looking Statements

Statements contained in this press release, other than statements of historical fact, particularly statements relating to cost reductions and the anticipated pre-tax savings from the cost reduction program, restructuring costs, footprint rationalization, simplifying and streamlining our operations, reducing complexity, enhancing the speed of decision-making, leveraging our sourcing capabilities and the timing of implementation and completion of the cost reduction program, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management based on information available to us at the time such statements are made. These statements, which are generally identifiable by the use of the words “will,” “believe,” “expect,” “intend,” “anticipate,” “estimate,” “forecast,” “project,” “plan,” and similar expressions, are subject to certain risks and uncertainties, are made as of the date hereof, and we undertake no duty or obligation to update them. Forward-looking statements are subject to the occurrence of many events outside the Company’s control and actual results and the timing of events may differ materially from those suggested or implied by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.

Media contact: Michael Eslinger ()



EN
04/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dalrada Financial Corp.

 PRESS RELEASE

Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Ac...

Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy. SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today that its wholly-owned healthcare subsidiary, Genefic, Inc. (“Genefic”), had acquired IV Services, LLC, a recognized pharmaceutical business and infusion management leader. The acquisition of IV Services expands Genefic’s existing pharmacy sales and operational footprint. Furthermore...

 PRESS RELEASE

Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter...

Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today it had filed a Form 10-Q for the quarter ended March 31, 2024, posting $10.3 million in revenue and highlighting consistent revenue generation, particularly from its specialty pharmacy subsidiary. “Q3 showed us that the pharmaceutical market is thriving. Driven by our subsidiary,...

 PRESS RELEASE

Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc....

Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market The pharmaceutical subsidiary plans on capturing a large portion of a growing market with an innovative prescription method. SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today that its wholly-owned healthcare subsidiary, (“Genefic”), has added a telemedicine service to its , allowing Genefic to efficiently offer clients direct access to its pharmaceuticals, including access to Genefic’s own wei...

 PRESS RELEASE

Dalrada Financial Corporation Files Patent Application for Proprietary...

Dalrada Financial Corporation Files Patent Application for Proprietary Technology that Creates Carbon Utility Tokens Company stakes its claim in the carbon market with unique software and hardware system that creates a solution for generating, validating, and trading carbon tokens. SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today that it had filed a provisional patent application with the United States Patent and Trademark Office for a unique system and method for mining carbon utility tokens. The announcement of the application (n...

 PRESS RELEASE

Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., forms Ad...

Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., forms Advisory Board and Announces Inaugural Members Experienced board members will help drive business strategy and execute ambitious goals in the booming home heat pump market. SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today the formation of the and named its board members for the new wholly-owned subsidiary that will focus on the development and distribution of heat pumps for residential use. News of the advisory board immediately follows the announcement of the —a dom...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch